Special Report:Super 4 Stocks for BTST
Super 4 Stocks for BTST
1.Gruh Finance Limited
The stock of Gruh Finance is looking bullish in near term. Investor can buy the stock at current level for the short term perspective. The stock found support at a long-term base level of 270 in mid-November, after a short-term corrective fall. Subsequently, the stock resumed its intermediate-term uptrend that has been in place since the February 2016 low of 227. Recently, the stock took support at 300 and resumed its uptrend. In last week, the stock gains around 10 per cent with good volume breaching the 21- and 50-DMAs. The daily moving average convergence divergence indicator is moving higher in line with the stock price and is likely to enter the positive territory. Overall, the stock appears to have resumed its intermediate-term uptrend. Traders with a short-term perspective can consider buying the stock with stop-loss at 311. The stock can extend its up move and reach the price targets of 335 and 345.
2.Nucleus Software Exports Limited
The overview for the stock Nucleus Software Exports is bullish. The stock break consolidation range in daily chart and continue the trend in near term. Following a medium-term downtrend, the stock found support at around 175 in late September and subsequently changed direction triggered by positive divergence in the daily MACD indicator and started the trend upwards. Reinforcing the uptrend Nucleus Software gained 10 per cent with good volume breaking through its immediate resistance at 250 on last week. This up move has also conclusively breached its 50- and 200-day moving averages. The daily RSI has entered the bullish zone from the neutral region and the weekly RSI is on the brink of entering this zone. Moreover buying interest is seen as the daily as well as weekly price rate of change indicators are featuring in the positive territory. The stock can reach the price target of 275 and 290 in the short term. Buy the stock with a stop-loss at 23
The company saw the drop of sale after the Demonetization initiative when the entire industry witnessed decline in sales. But year end the impact of demonetization decreases, technically the continuous fall of stock prices of hero yesterday we saw a bit correction in daily chart. From the next trading session buyers can take the position when the prices retrace to the level of 3040-3050. The immediate resistance is 3100 and 3150. So we recommended that buyer can take long position from the level of 3040-3050 and can take the profit part till the prices come 3100 and the next would be 3150 And put the risk part can be taken at below the level of 2990.
Technically we observe that there is a formation of hook reversal pattern in daily chart. And also we found that there is consolidation between the ranges of 610-630. So, if it break the range prices would break the level of 630 price would be breach to the level of 650, the next upcoming resistance would be 667. The immediate support is 610. So that traders can take long position from current above 630, and can book the profit when it comes to the level 640 or 665 and can put the risk part below the level of 610. Sun Pharma, India’s largest drug maker last week said it will acquire Novartis’s branded skin cancer drug Odomzo. Sun has agreed to pay USD 175 million or close to Rs 1200 crore upfront and additional milestone payments for the proposed acquisition, which needs to go through anti-trust regulation. According to analysts the product is expected to generate USD60-80 million (Rs 400-550 crore) in annual sales for the company.